Antipsychotic drugs, QT-prolongation and the risk of cardiac arrhythmias: Implications for clinical practice;Antipsychotica, QT-verlenging en het risico van hartritmestoornissen: Consequenties voor de klinische praktijk

Tijdschrift voor Psychiatrie

Volumn 43, Issue 11, 2001, Pages 787-791

  Zoeteman, J B ^a   Meesters, P D ^a   Wilde, A A M ^a  

^a JellinekMentrum   (Netherlands)

Author keywords

Antipsychotic drugs; Cardiac arrhythmia; Electrocardiogram; QT prolongation

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; CLINICAL PRACTICE; DRUG MEGADOSE; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HUMAN; LONG QT SYNDROME; RISK FACTOR;

EID: 0035161465     PISSN: 03037339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Anoniem
2. Cardiotoxicity more common in thioridazine overdose than with other neuroleptics
3. The potential for QT prolongation and pro-arrhythmia by non-antiarrhythmic drugs: Clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology
4. Torsade de pointes and low-dose oral haloperidol
5. Electrocardiographic abnormalities in patients treated with clozapine
6. Thioridazine hydrochloride (Mellaril): Its effect on the electrocardiogram and a report of two fatalities with electrocardiographic abnormalities
7. Long-term treatment with antipsychotic drugs in conventional doses prolonged QTC dispersion, but did not increase ventricular tachyarrhythmias in patients with schizophrenia in the absence of cardiac disease
8. Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: A review of the literature
9. Diurnal pattern of QTC interval: How long is prolonged? Possible relation to circadian triggers of cardiovascular events
10. QTC-Interval abnormalities and psychotropic drug therapy in psychiatric patients
11. Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes
12. Electrocardiographic changes in patients receiving neuroleptic medication
13. Antipsychotic agents and QT changes